{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T20:32:52Z","timestamp":1792528372562,"version":"4.5.0"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Virology"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.coviro.2020.07.005","type":"journal-article","created":{"date-parts":[[2020,8,9]],"date-time":"2020-08-09T12:29:02Z","timestamp":1596976142000},"page":"90-96","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Modeling oncogenic herpesvirus infections in humanized mice"],"prefix":"10.1016","volume":"44","author":[{"given":"Philip T","family":"Lange","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blossom","family":"Damania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coviro.2020.07.005_bib0005","doi-asserted-by":"crossref","first-page":"3030","DOI":"10.1002\/ijc.21731","article-title":"The global health burden of infection-associated cancers in the year 2002","volume":"118","author":"Parkin","year":"2006","journal-title":"Int J Cancer"},{"key":"10.1016\/j.coviro.2020.07.005_bib0010","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S1470-2045(09)70096-8","article-title":"A review of human carcinogens\u2014Part B: biological agents","volume":"10","author":"Bouvard","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.coviro.2020.07.005_bib0015","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1172\/JCI84418","article-title":"Kaposi sarcoma\u2013associated herpesvirus: immunobiology, oncogenesis, and therapy","volume":"126","author":"Dittmer","year":"2020","journal-title":"J Clin Invest"},{"key":"10.1016\/j.coviro.2020.07.005_bib0020","doi-asserted-by":"crossref","first-page":"4178","DOI":"10.3390\/v6114178","article-title":"Epidemiology and transmission of Kaposi\u2019s sarcoma-associated herpesvirus","volume":"6","author":"Minhas","year":"2014","journal-title":"Viruses"},{"key":"10.1016\/j.coviro.2020.07.005_bib0025","doi-asserted-by":"crossref","DOI":"10.7189\/jogh.10.010404","article-title":"Predictors of Epstein-Barr virus serostatus and implications for vaccine policy: a systematic review of the literature","volume":"10","author":"Winter","year":"2020","journal-title":"J Glob Health"},{"key":"10.1016\/j.coviro.2020.07.005_bib0030","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/nrc.2016.92","article-title":"Epstein\u2013Barr virus: more than 50 years old and still providing surprises","volume":"16","author":"Young","year":"2016","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.coviro.2020.07.005_bib0035","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2017.00613","article-title":"Reactivation and lytic replication of Kaposi\u2019s sarcoma-associated herpesvirus: an update","volume":"8","author":"Aneja","year":"2017","journal-title":"Front Microbiol"},{"key":"10.1016\/j.coviro.2020.07.005_bib0040","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S1040-8428(02)00112-9","article-title":"Immunological aspects of Epstein\u2013Barr virus infection","volume":"44","author":"Ohga","year":"2002","journal-title":"Crit Rev Oncol\/Hematol"},{"key":"10.1016\/j.coviro.2020.07.005_bib0045","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.exger.2007.01.005","article-title":"Chronic herpesvirus reactivation occurs in aging","volume":"42","author":"Stowe","year":"2007","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.coviro.2020.07.005_bib0050","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1002\/jmv.21485","article-title":"Serological evidence for long-term epstein\u2013barr virus reactivation in children living in a holoendemic malaria region of Kenya","volume":"81","author":"Piriou","year":"2009","journal-title":"J Med Virol"},{"key":"10.1016\/j.coviro.2020.07.005_bib0055","first-page":"818","article-title":"Lymphoproliferative disease in mice infected with murine gammaherpesvirus 68","volume":"145","author":"Sunil-Chandra","year":"1994","journal-title":"Am J Pathol"},{"key":"10.1016\/j.coviro.2020.07.005_bib0060","doi-asserted-by":"crossref","first-page":"14668","DOI":"10.1128\/JVI.79.23.14668-14679.2005","article-title":"Murine gammaherpesvirus 68 infection is associated with lymphoproliferative disease and lymphoma in BALB \u03b22 microglobulin-deficient mice","volume":"79","author":"Tarakanova","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2020.07.005_bib0065","doi-asserted-by":"crossref","first-page":"5481","DOI":"10.1158\/0008-5472.CAN-09-0291","article-title":"Murine gammaherpesvirus 68 infection of IFNgamma unresponsive mice: a small animal model for gammaherpesvirus-associated B-cell lymphoproliferative disease","volume":"69","author":"Lee","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.coviro.2020.07.005_bib0070","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01053-18","article-title":"In vivo models of oncoproteins encoded by Kaposi\u2019s sarcoma-associated herpesvirus","volume":"93","author":"Bravo Cruz","year":"2019","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2020.07.005_bib0075","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1146\/annurev-virology-100114-054908","article-title":"Transgenic mouse models of tumor virus action","volume":"3","author":"Lambert","year":"2016","journal-title":"Annu Rev Virol"},{"key":"10.1016\/j.coviro.2020.07.005_sbref0080","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1172\/JCI76357","article-title":"LMP1-deficient Epstein-Barr virus mutant requires T cells for lymphomagenesis","volume":"125","author":"Ma","year":"2015","journal-title":"J Clin Invest"},{"key":"10.1016\/j.coviro.2020.07.005_bib0085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007221","article-title":"An EBNA3C-deleted Epstein-Barr virus (EBV) mutant causes B-cell lymphomas with delayed onset in a cord blood-humanized mouse model","volume":"14","author":"Romero-Masters","year":"2018","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coviro.2020.07.005_sbref0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005642","article-title":"PD-1\/CTLA-4 blockade inhibits Epstein-Barr virus-induced lymphoma growth in a cord blood humanized-mouse model","volume":"12","author":"Ma","year":"2016","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coviro.2020.07.005_bib0095","doi-asserted-by":"crossref","first-page":"3462","DOI":"10.1158\/1078-0432.CCR-13-0855","article-title":"PD-L1 expression is characteristic of a subset of aggressive B-cell lymphomas and virus-associated malignancies","volume":"19","author":"Chen","year":"2013","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.coviro.2020.07.005_bib0100","doi-asserted-by":"crossref","first-page":"9150","DOI":"10.1073\/pnas.90.19.9150","article-title":"Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation","volume":"90","author":"Kaye","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coviro.2020.07.005_bib0105","doi-asserted-by":"crossref","first-page":"11963","DOI":"10.1073\/pnas.95.20.11963","article-title":"Expression of the Epstein\u2013Barr virus latent membrane protein 1 induces B cell lymphoma in transgenic mice","volume":"95","author":"Kulwichit","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coviro.2020.07.005_bib0110","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.cell.2011.12.031","article-title":"Immune surveillance and therapy of lymphomas driven by Epstein-Barr virus protein LMP1 in a mouse model","volume":"148","author":"Zhang","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.coviro.2020.07.005_bib0115","series-title":"Epstein Barr Virus Volume 2","first-page":"151","article-title":"Latent membrane protein 2 (LMP2)","author":"Cen","year":"2015"},{"key":"10.1016\/j.coviro.2020.07.005_bib0120","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S1074-7613(00)80623-8","article-title":"Epstein-Barr virus LMP2A drives B cell development and survival in the absence of normal B cell receptor signals","volume":"9","author":"Caldwell","year":"1998","journal-title":"Immunity"},{"key":"10.1016\/j.coviro.2020.07.005_bib0125","doi-asserted-by":"crossref","first-page":"17945","DOI":"10.1073\/pnas.0907994106","article-title":"Epstein-Barr virus LMP2A bypasses p53 inactivation in a MYC model of lymphomagenesis","volume":"106","author":"Bieging","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coviro.2020.07.005_bib0130","doi-asserted-by":"crossref","first-page":"4339","DOI":"10.1182\/blood-2005-06-2341","article-title":"Rescue of \u201ccrippled\u201d germinal center B cells from apoptosis by Epstein-Barr virus","volume":"106","author":"Mancao","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.coviro.2020.07.005_bib0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002662","article-title":"Epstein-Barr virus LMP2A reduces hyperactivation induced by LMP1 to restore normal B cell phenotype in transgenic mice","volume":"8","author":"Vrazo","year":"2012","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coviro.2020.07.005_sbref0140","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01928-16","article-title":"Latent Membrane Protein 1 (LMP1) and LMP2A collaborate to promote Epstein-Barr virus-induced B cell lymphomas in a cord blood-humanized mouse model but are not essential","volume":"91","author":"Ma","year":"2017","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2020.07.005_bib0145","doi-asserted-by":"crossref","first-page":"13891","DOI":"10.1128\/JVI.78.24.13891-13900.2004","article-title":"Experimental Infection of NOD\/SCID mice reconstituted with human CD34+ cells with Epstein-Barr virus","volume":"78","author":"Islas-Ohlmayer","year":"2004","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2020.07.005_bib0150","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.2353\/ajpath.2008.071186","article-title":"CD34+ cord blood cell-transplanted Rag2\u2212\/\u2212 \u03b3c\u2212\/\u2212 mice as a model for Epstein-Barr virus infection","volume":"173","author":"Cocco","year":"2008","journal-title":"Am J Pathol"},{"key":"10.1016\/j.coviro.2020.07.005_bib0155","doi-asserted-by":"crossref","first-page":"e01574","DOI":"10.1128\/mBio.01574-15","article-title":"Knockout of Epstein-Barr virus BPLF1 retards B-cell transformation and lymphoma formation in humanized mice","volume":"6","author":"Whitehurst","year":"2015","journal-title":"mBio"},{"key":"10.1016\/j.coviro.2020.07.005_sbref0160","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00813-18","article-title":"Epstein-Barr virus Type 2 infects T cells and induces B cell lymphomagenesis in humanized mice","volume":"92","author":"Coleman","year":"2018","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2020.07.005_bib0165","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1086\/590502","article-title":"a new humanized mouse model of epstein-barr virus infection that reproduces persistent infection, lymphoproliferative disorder, and cell-mediated and humoral immune responses","volume":"198","author":"Yajima","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coviro.2020.07.005_bib0170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007039","article-title":"EBV persistence without its EBNA3A and 3C oncogenes in vivo","volume":"14","author":"Murer","year":"2018","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coviro.2020.07.005_bib0175","doi-asserted-by":"crossref","first-page":"5437","DOI":"10.1128\/JVI.00281-13","article-title":"A cluster of virus-encoded MicroRNAs accelerates acute systemic Epstein-Barr virus infection but does not significantly enhance virus-induced oncogenesis in vivo","volume":"87","author":"Wahl","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2020.07.005_sbref0180","article-title":"MicroRNAs of Epstein-Barr virus attenuate T-cell-mediated immune control in vivo","volume":"10","author":"Murer","year":"2019","journal-title":"mBio"},{"key":"10.1016\/j.coviro.2020.07.005_bib0185","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1093\/infdis\/jix363","article-title":"Epstein-Barr virus Type 2 infects T cells in healthy Kenyan children","volume":"216","author":"Coleman","year":"2017","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coviro.2020.07.005_bib0190","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1128\/JVI.03001-14","article-title":"Epstein-Barr virus Type 2 latently infects T cells, inducing an atypical activation characterized by expression of lymphotactic cytokines","volume":"89","author":"Coleman","year":"2015","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2020.07.005_bib0195","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004333","article-title":"Adoptive transfer of EBV specific CD8+ T cell clones can transiently control EBV infection in humanized mice","volume":"10","author":"Antsiferova","year":"2014","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coviro.2020.07.005_bib0200","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007748","article-title":"CD8+ T cells retain protective functions despite sustained inhibitory receptor expression during Epstein-Barr virus infection in vivo","volume":"15","author":"Chatterjee","year":"2019","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coviro.2020.07.005_bib0205","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1093\/infdis\/jiv114","article-title":"Role of the 2B4 receptor in CD8+ T-cell-dependent immune control of Epstein-Barr virus infection in mice with reconstituted human immune system components","volume":"212","author":"Chijioke","year":"2015","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coviro.2020.07.005_bib0210","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1182\/bloodadvances.2018025536","article-title":"Plasmacytoid dendritic cells respond to Epstein-Barr virus infection with a distinct type I interferon subtype profile","volume":"3","author":"Gujer","year":"2019","journal-title":"Blood Adv"},{"key":"10.1016\/j.coviro.2020.07.005_bib0215","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1182\/blood-2008-03-148072","article-title":"Targeting the nuclear antigen 1 of Epstein-Barr virus to the human endocytic receptor DEC-205 stimulates protective T-cell responses","volume":"112","author":"Gurer","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.coviro.2020.07.005_sbref0220","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1172\/JCI125364","article-title":"Heterologous prime-boost vaccination protects against EBV antigen\u2013expressing lymphomas","volume":"129","author":"R\u00fchl","year":"2019","journal-title":"J Clin Invest"},{"key":"10.1016\/j.coviro.2020.07.005_bib0225","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007464","article-title":"Immunogenic particles with a broad antigenic spectrum stimulate cytolytic T cells and offer increased protection against EBV infection ex vivo and in mice","volume":"14","author":"van Zyl","year":"2018","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coviro.2020.07.005_bib0230","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1126\/science.2971269","article-title":"The SCID-hu mouse: murine model for the analysis of human hematolymphoid differentiation and function","volume":"241","author":"McCune","year":"1988","journal-title":"Science"},{"key":"10.1016\/j.coviro.2020.07.005_bib0235","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1084\/jem.172.4.1055","article-title":"Long-term human hematopoiesis in the SCID-hu mouse","volume":"172","author":"Namikawa","year":"1990","journal-title":"J Exp Med"},{"key":"10.1016\/j.coviro.2020.07.005_sbref0240","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1038\/nm1431","article-title":"Humanized mice mount specific adaptive and innate immune responses to EBV and TSST-1","volume":"12","author":"Melkus","year":"2006","journal-title":"Na Med"},{"key":"10.1016\/j.coviro.2020.07.005_bib0245","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1084\/jem.20062411","article-title":"Intrarectal transmission, systemic infection, and CD4+ T cell depletion in humanized mice infected with HIV-1","volume":"204","author":"Sun","year":"2007","journal-title":"J Exp Med"},{"key":"10.1016\/j.coviro.2020.07.005_bib0250","doi-asserted-by":"crossref","first-page":"7582","DOI":"10.1128\/JVI.00537-11","article-title":"One percent Tenofovir applied topically to humanized BLT mice and used according to the CAPRISA 004 experimental design demonstrates partial protection from vaginal HIV infection, validating the BLT model for evaluation of new microbicide candidates","volume":"85","author":"Denton","year":"2011","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2020.07.005_bib0255","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.1073\/pnas.1318175111","article-title":"Humanized-BLT mouse model of Kaposi\u2019s sarcoma-associated herpesvirus infection","volume":"111","author":"Wang","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coviro.2020.07.005_bib0260","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1128\/JVI.01512-10","article-title":"A new model of Epstein-Barr virus infection reveals an important role for early lytic viral protein expression in the development of lymphomas","volume":"85","author":"Ma","year":"2011","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2020.07.005_bib0265","doi-asserted-by":"crossref","first-page":"7976","DOI":"10.1128\/JVI.00770-12","article-title":"An Epstein-Barr Virus (EBV) mutant with enhanced BZLF1 expression causes lymphomas with abortive lytic EBV infection in a humanized mouse model","volume":"86","author":"Ma","year":"2012","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2020.07.005_sbref0270","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1084\/jem.190.12.1857","article-title":"Experimental transmission of Kaposi\u2019s sarcoma-associated herpesvirus (KSHV\/HHV-8) to SCID-hu Thy\/Liv mice","volume":"190","author":"Dittmer","year":"1999","journal-title":"J Exp Med"},{"key":"10.1016\/j.coviro.2020.07.005_bib0275","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1172\/JCI27249","article-title":"KSHV targets multiple leukocyte lineages during long-term productive infection in NOD\/SCID mice","volume":"116","author":"Parsons","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1016\/j.coviro.2020.07.005_bib0280","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1182\/blood-2005-04-1697","article-title":"KSHV\/HHV-8 infection of human hematopoietic progenitor (CD34+) cells: persistence of infection during hematopoiesis in vitro and in vivo","volume":"108","author":"Wu","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.coviro.2020.07.005_bib0285","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02071-18","article-title":"LXR alpha restricts gammaherpesvirus reactivation from latently infected peritoneal cells","volume":"93","author":"Lange","year":"2019","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2020.07.005_bib0290","doi-asserted-by":"crossref","first-page":"6134","DOI":"10.1128\/JVI.00108-07","article-title":"Gamma interferon blocks gammaherpesvirus reactivation from latency in a cell type-specific manner","volume":"81","author":"Steed","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2020.07.005_bib0295","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.virol.2016.02.022","article-title":"Gammaherpesvirus targets peritoneal B-1 B cells for long-term latency","volume":"492","author":"Rekow","year":"2016","journal-title":"Virology"},{"key":"10.1016\/j.coviro.2020.07.005_bib0300","doi-asserted-by":"crossref","first-page":"3273","DOI":"10.1128\/JVI.73.4.3273-3283.1999","article-title":"Macrophages are the major reservoir of latent murine gammaherpesvirus 68 in peritoneal cells","volume":"73","author":"Weck","year":"1999","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2020.07.005_sbref0305","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.chom.2017.06.009","article-title":"Persistent KSHV infection increases EBV-associated tumor formation in vivo via enhanced EBV lytic gene expression","volume":"22","author":"McHugh","year":"2017","journal-title":"Cell Host Microbe"}],"container-title":["Current Opinion in Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879625720300481?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879625720300481?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T10:04:59Z","timestamp":1761818699000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1879625720300481"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":61,"alternative-id":["S1879625720300481"],"URL":"https:\/\/doi.org\/10.1016\/j.coviro.2020.07.005","relation":{},"ISSN":["1879-6257"],"issn-type":[{"value":"1879-6257","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Modeling oncogenic herpesvirus infections in humanized mice","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coviro.2020.07.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}